The report with the updated recommendation ... pneumonia, meningitis and bloodstream infections. On Oct. 23, 2024, the Advisory Committee on Immunization Practices (ACIP), which advises the CDC ...

Merck (NYSE:MRK) announced that a group of independent advisors to the U.S. CDC unanimously voted to recommend its newly approved pneumonia vaccine, Capvaxive, for adults aged 65 years and older.

The CDC made its recommendation ... who are also recommended for the vaccine. In addition to lowering the age recommendation for the pneumonia shot, the health agency this fall recommended a ...